Herpes Simplex Virus Infection Linked to Increased Risk of Vitiligo, Study Suggests

Written By :  Medha Baranwal
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2024-12-17 15:30 GMT   |   Update On 2024-12-17 15:31 GMT

Taiwan: A nationwide retrospective cohort study has revealed a significant association between herpes simplex virus (HSV) infection and an increased risk of developing vitiligo, a chronic skin condition characterized by the loss of pigment in patches of the skin. This population-based study, published in Archives of Dermatological Research, offers new insights into the potential role of viral infections in the pathogenesis of autoimmune diseases like vitiligo.

Results indicated that individuals with a history of HSV infection were more likely to develop vitiligo over time, suggesting a potential link between the two conditions. The findings emphasize the importance of considering viral infections as a possible contributing factor in the onset of autoimmune and inflammatory skin disorders.

Several studies have suggested a potential link between herpes simplex virus infection and the development of vitiligo. Jing-Xing Li, Department of Internal Medicine, China Medical University Hospital, Number 2, Yude Road, North District, Taichung, Taiwan, and colleagues aimed to investigate the association between HSV infection and the risk of vitiligo.

For this purpose, the researchers utilized the National Health Insurance Research Database of Taiwan to conduct a comparative analysis between individuals with and without a diagnosis of HSV infection. The study covered the period from January 1, 2008, to December 31, 2019. The primary outcome included the date of the first vitiligo diagnosis, death, withdrawal from the National Health Insurance Program, or the conclusion of the study period.

The study led to the following findings:

  • A 1:1 propensity score matching was performed based on age, sex, and comorbidities, resulting in 1,009,445 matched pairs of patients with and without HSV infections.
  • The adjusted hazard ratio for developing vitiligo in the HSV-infected group was 1.71.
  • An age-dependent pattern was observed among HSV-infected patients with vitiligo.
  • Both males and females showed a significantly higher risk of developing vitiligo in the presence of HSV infection.
  • The HSV-infected group demonstrated a significantly increased cumulative risk of vitiligo over a 12-year follow-up compared to the non-HSV group.
  • Sensitivity analysis confirmed results consistent with the primary analysis.
  • The risk of vitiligo was notably higher within the first year of follow-up among HSV-infected patients compared to the non-HSV group (adjusted hazard ratio, 4.83).

"The study establishes a notable link between HSV infection and an elevated risk of vitiligo, marking a significant step toward unraveling the complex interplay between viral infections and autoimmune disorders. However, further research, including molecular studies of affected skin regions, is essential to confirm causality and explore the underlying mechanisms of this association," the researchers concluded.

Reference:

Li, JX., Yu, TS., Hsu, SB. et al. Association of herpes simplex virus infection and vitiligo: a nationwide retrospective cohort study. Arch Dermatol Res 317, 90 (2025). https://doi.org/10.1007/s00403-024-03612-x


Tags:    
Article Source : Archives of Dermatological Research

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News